About Annals of the Rheumatic Diseases
Aims and Scope
Annals of the Rheumatic Diseases (ARD) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer reviewed proceedings of international meetings are featured. Educational papers include state of the art reviews, "how to" articles and educational cases that focus on problems faced in clinical practice. The journal was first published in 1939 and has an authorative global Editorial Board and a growing international readership.
ARD is co-owned by the European League Against Rheumatism (EULAR) and BMJ Group.
|Acceptance rate||24% for original research submitted in 2012|
|Time from submission to first decision||
|Time from acceptance to publication||
29 days (online)
|Indexed by||Science Citation Index, Index Medicus (Medline), Excerpta Medica (Embase), BIOSIS Previews, Sociedad Iberoamericana de Informacion Cientifica (SIIC)|
|ISSN of ARD||0003-4967|
|ISSN of ARD Online||1468-2060|
For all contact information please refer to the Contact Us page.
Please refer to the Instructions for Authors
Rights and Permissions
- ARD is the official journal of EULAR - the European League Against Rheumatism and all (scientific) delegates to the annual EULAR congress receive a complimentary 12 month subscription to the journal.
The BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting transparent, accurate reporting of research studies. The BMJ Group is a sponsor of its activities.
Register for free content
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ARD.
View free sample issue >>
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.